The drug firm, however, did not provide any details of the contents of
the warning letter received from the regulator.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-warning-letter-from-usfda-for-andhra-pradesh-unit/articleshow/69885651.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment